Teva

MITOXANTRONE HCL

View Prices
  1. Home
    2.  / 
  2. J Code
    3.  / MITOXANTRONE HCL – J9293

Manufacturer:

Teva

Name:

MITOXANTRONE HCL

HCPCS Code Descriptor:

Injection, mitoxantrone hydrochloride, per 5 mg

Category:

J Code

HCPCS:

J9293

NDC(s):

63323-0132-15, 63323-0132-10, 63323-0132-12, 61703-0343-65, 61703-0343-66, 61703-0343-18, 00703-4680-01, 00703-4685-01, 00703-4686-01

Primary Type:

Oncology

Generic Status:

Multi-Source

Route of Administration:

Intravenous

About:

MITOXANTRONE HCL is an Oncology drug manufactured by Teva and administered via the Intravenous route of administration. The J Code: J9293 is aligned to the drug MITOXANTRONE HCL.

View Prices

Access Pricing and More By Registering

Register Now

HCPCS Added Date:

1/1/90

HCPCS Effective Date:

1/1/97

HCPCS Short Description:

Mitoxantrone hydrochl / 5 mg

Billing and Coding Guide:

Not Found

Patient Assistance:

Not Found